Table 2.

Distribution of sociodemographic and baseline clinical characteristics of patients (n = 4928)

Characteristic	N (%)
Sociodemographic
Age, years: Median [range]	65 [30–91]
< 65	2304 (46.8)
65 – 74	1896 (38.5)
75 – 80	569 (11.5)
> 80	159 (3.2)
Sex
Male	2732 (55.4)
Female	2196 (44.6)
Race
White	4062 (82.4)
Asian	428 (8.7)
Black	114 (2.3)
Other	70 (1.4)
Unknown/ Not reported	254 (5.2)
Ethnicity
Hispanic/ Latino	165 (3.3)
Not Hispanic or Latino	3904 (79.2)
Not reported	859 (17.4)
Geographic Region
United States of America	345 (7)
Non-United States of America	4583 (93)
Clinical
ISS Stage
Stage I	2256 (45.8)
Stage II	1582 (32.1)
Stage III	1034 (21)
Missing/unknown	56 (1.1)
Number of prior lines of treatment
1	1919 (38.9)
2 or 3	2578 (52.3)
≥ 4	428 (8.7)
Missing/unknown	3 (0.1)
ECOG Performance Status
0–Fully active, able to carry on all pre-disease performance without restriction	1954 (39.8)
1–Restricted in physical strenuous activity but ambulatory and able to carry out work of a light or   sedentary nature	2383 (48.5)
2–Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours	545 (11.1)
3–Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours	31 (0.6)
4–Completely disabled; cannot carry on selfcare; totally confined to bed or chair	0
Not reported	15 (0.3)
EORTC QLQ-C30 Physical Functioning Subscale summary score: Median [interquartile range]	73 [53–87]
Charlson Comorbidity Index
0	2951 (59.9)
1	1190 (24.1)
2	527 (10.7)
3	161 (3.3)
4	65 (1.3)
5 +	34 (0.7)

ISS International Staging System, ECOG Eastern Cooperative Oncology Group, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life 30-item Questionnaire